$CYTK
Price history, market instrument context, member research, and related headlines in one place.
CYTK key statistics
NasdaqGSUSD
52-week range
$54.3028%$88.31
Latest session $63.81–$65.57Cytokinetics, Incorporated (CYTK) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $63.92, up $0.49 (0.77%) from the previous close of $63.43. It has traded between $63.81 and $65.57 in the latest session. Over the past year it has ranged from $54.30 to $88.31, leaving it in the lower half of its 52-week range (28%). Reported volume for the session was 1.7M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
H.C. Wainwright reiterates Cytokinetics stock rating on patent suit — See source for full details.
Cytokinetics targets >50% MYQORZO new-to-brand share by end of 2026 while planning nHCM sNDA in Q4 — See source for full details.
Form 144 CYTOKINETICS For: 30 July — See source for full details.
Cytokinetics wins U.K. nod, NICE endorsement for heart drug — See source for full details.
Cytokinetics president & CEO Robert Blum sells $606,525 in stock — See source for full details.
Loading $CYTK research…